Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 3.64B | £ 3.50B | £ 3.54B | £ 2.33B | £ 2.32B |
Total Assets | £ 10.45B | £ 10.34B | £ 9.77B | £ 8.31B | £ 8.47B |
Total Debt | £ 4.31B | £ 4.10B | £ 4.45B | £ 4.35B | £ 3.44B |
Net Debt | £ 670.00M | £ 596.00M | £ 910.00M | £ 2.02B | £ 1.13B |
Total Liabilities | £ 7.92B | £ 7.89B | £ 7.13B | £ 6.73B | £ 6.57B |
Stockholders Equity | £ 2.53B | £ 2.44B | £ 2.64B | £ 1.58B | £ 1.90B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |